Your session is about to expire
← Back to Search
Mobile Case Management for Heart Rehabilitation (iCARE Trial)
N/A
Recruiting
Led By Thomas P Olson, Ph.D., M.S.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients who have a history of one of the following; acute myocardial infarction/acute coronary syndrome, stable angina pectoris, percutaneous coronary intervention, or heart failure.
Patients who have undergone a surgical procedure which includes an indication for cardiac rehabilitation (coronary artery bypass surgery, heart valve repair/replacement, or heart transplant)
Must not have
Patients referred to cardiac rehab with ventricular assist devices.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing if doing cardiac rehab at home is just as effective as coming in to the clinic.
Who is the study for?
This trial is for heart patients with conditions like a recent heart attack, angina, or those who've had certain heart surgeries. Participants need to have access to a smartphone or computer with internet and an email address. It's not for those using ventricular assist devices.
What is being tested?
The study is testing if cardiac rehabilitation done at home (with or without clinic visits) can be as effective as the traditional approach of only attending sessions in a medical center.
What are the potential side effects?
Since this trial involves non-drug interventions like exercise and education programs, side effects may include typical risks associated with physical activity such as muscle soreness or strain.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have a history of heart issues, including heart attack, stable chest pain, heart surgery, or heart failure.
Select...
I had heart surgery that requires cardiac rehab.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have a ventricular assist device and am referred to cardiac rehab.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Functional Capacity
Number of participants who are re-hospitalized during the trial
Secondary study objectives
6 Minute Walk Test
Change in Body Weight
Fasting Basic Lipid Panel
+6 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Active Control
Group I: Conventional Center-Based Cardiac Rehab + mHealth (CON+)Active Control2 Interventions
Participants will be prescribed 36 sessions of center-based CR as noted above. In addition, participants will be provided access to the mHealth platform which provides "e-Learning modules" with factsheets, videos, quizzes, and questionnaires (coinciding with activities being conducted during the CON program), a Social Network Module will allow patients to communicate via secure network with other patients who are part of their invited network. The Social Network Module also allows for secure two-way interaction with healthcare providers in the event that patients are experiencing signs or symptoms suggestive of worsening condition. This platform also contains a Personal Health Record Module allowing patients to upload, archive, and retrieve personal health data (e.g. fitness tracker data, heart rate monitor data, blood pressure recordings, etc.) and record vital signs, symptoms, treatments, and medical history.
Group II: Conventional Center-Based Cardiac Rehab (CON)Active Control1 Intervention
Participants will be prescribed 36 sessions of center-based CR. This includes supervised exercise sessions, cooking demonstrations, didactic lectures, video presentations, group support, and stress management education. During sessions, participants have direct access to the medical director, case manager, registered nurse, exercise physiologist, and stress management specialists.
Group III: Home-Based Cardiac Rehab + mHealth (HOM+)Active Control2 Interventions
Participants will be provided paper copies of educational content at the time of event/discharge. In addition, these participants will be provided access to the same mHealth platform as the CON+ group. Participants in this group will be encouraged to exercise three days per week while also completing the additional questionnaires and educational content provided by the mHealth platform in accordance with the CR program. Participation will be tracked using web/internet analytics.
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,344 Previous Clinical Trials
3,062,070 Total Patients Enrolled
7 Trials studying Acute Coronary Syndrome
7,116 Patients Enrolled for Acute Coronary Syndrome
National Institute of Nursing Research (NINR)NIH
600 Previous Clinical Trials
10,377,246 Total Patients Enrolled
Thomas P Olson, Ph.D., M.S.Principal InvestigatorMayo Clinic
1 Previous Clinical Trials
187 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a ventricular assist device and am referred to cardiac rehab.I have a history of heart issues, including heart attack, stable chest pain, heart surgery, or heart failure.I had heart surgery that requires cardiac rehab.
Research Study Groups:
This trial has the following groups:- Group 1: Conventional Center-Based Cardiac Rehab + mHealth (CON+)
- Group 2: Conventional Center-Based Cardiac Rehab (CON)
- Group 3: Home-Based Cardiac Rehab + mHealth (HOM+)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger